Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

BACKGROUND: A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). Although macrolide has proven efficacy, the role of ethambutol and rifampicin in patients without acquired immune deficiency syndrome i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung-Jun, Lee, Jong Sik, Kwak, Nakwon, Cho, Jaeyoung, Lee, Chang-Hoon, Han, Sung Koo, Yim, Jae-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849249/
https://www.ncbi.nlm.nih.gov/pubmed/31711459
http://dx.doi.org/10.1186/s12890-019-0982-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849249/
https://www.ncbi.nlm.nih.gov/pubmed/31711459
http://dx.doi.org/10.1186/s12890-019-0982-8

Ejemplares similares